Zymeworks Inc. (NYSE:ZYME) Receives $21.00 Average Price Target from Analysts
Zymeworks Inc. (NYSE:ZYME – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the ten brokerages that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the […]
Zymeworks Inc. (NYSE:ZYME – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the ten brokerages that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the […]
